Stocks · Korea
471820
KOSDAQ
Cellromax Science
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
PER15.45x
PBR0.97x
EPS264 KRW
BPS4,202 KRW
ROE-1.55%
Dividend yield4.53%
DPS185 KRW
Payout ratio70.08%
Returns and 52-week range
1W+1.12%
1M-0.37%
3M-9.03%
6M-17.58%
1Y-36.05%
YTD-41.46%
52W high7,690원
52W low3,410원
From 52W high-46.94%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2025 | 222억 | 28억 | 0원 | 12.8% |
| Quarterly | ||||
| 2025 1Q | 59억 | 9억 | 7억 | 14.4% |
| 2025 2Q | 65억 | 12억 | 12억 | 17.9% |
| 2025 3Q | 53억 | 7억 | 8억 | 13.8% |
| 2025 4Q | 45억 | 86,388,494원 | -27억 | 1.9% |
| 2026 1Q | 47억 | 3억 | 0원 | 7.4% |
Company
Address: 경기도 용인시 기흥구 구성로 357 D동 710호 (청덕동, 용인테크노밸리)
Peers in the same sector
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-06-29[기재정정]사업보고서 (2025.12)
- 2026-05-15분기보고서 (2026.03)
- 2026-04-20주요사항보고서(자기주식취득신탁계약체결결정) Major
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.